about
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.Real-world evaluation of compliance and preference in Alzheimer's disease treatment.Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.ACE Gene in Egyptian Ischemic Stroke Patients.Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.Elevated serum Bcl-2 in children with temporal lobe epilepsy.
P50
Q35093103-D947B605-6CC5-440D-BA17-B8A51A8D77D8Q36264977-33B4337E-4FC9-4247-AC4D-D517A2AFA6B2Q38636586-8BFED4C8-4FD6-4596-8ADF-91865F180F91Q39273975-3AE0791F-6A2E-4561-A0B7-F565BBF0DFF1Q39621576-8F2528AC-4D9E-431E-B55A-578C56545A15Q47354170-86CCF9DD-7D22-4FEA-ABA4-9AE0F5B70893Q48641289-067750DD-473A-45EC-BA37-33D416A8DB26
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-1497-7915
@en
name
Hany M Aref
@ast
Hany M Aref
@en
Hany M Aref
@es
Hany M Aref
@nl
type
label
Hany M Aref
@ast
Hany M Aref
@en
Hany M Aref
@es
Hany M Aref
@nl
prefLabel
Hany M Aref
@ast
Hany M Aref
@en
Hany M Aref
@es
Hany M Aref
@nl
P106
P1153
55006485900
P31
P496
0000-0003-1497-7915